Chemcon Speciality Chemicals Ltd
Chemcon Speciality Chemicals Ltd Q3 FY25 Results & Presentation Highlights: Revenue, Margins & Order Book
Q3 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on Chemcon Speciality Chemicals Ltd's Q3 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q3 FY25 Revenue from Operations: Rs. Q3 FY25 EBITDA: Rs.
From Chemcon Speciality Chemicals Ltd's Q3 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
2 more points management made on revenue & sales performance
Profitability & Margins
See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Capacity expansion plans to add two new manufacturing units, P10 and P11, for organic chemicals. (Page 20, 18)
- Proposed P-10 and P-11 units targeted for commissioning in H1FY26. (Page 18)
- Existing installed capacity includes 11,400 MTPA for organic chemicals and 15,000 MTPA for inorganic chemicals. (Page 18)
- Ongoing cost-efficiency improvements through process re-engineering and economies of scale. (Page 20)
- Growth drivers include new products, clients, applications, and import substitution strategies focusing on organic chemicals. (Page 20, 21)
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹75 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemcon Speciality Chemicals Ltd's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q2 FY24 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q1 FY22 earnings call →
- Q4 FY21 earnings call →
Others in Chemicals & Petrochemicals this season
- Himadri Speciality Chemical Ltd (Q3 FY25)
1,131.81 Crs, up 7.53% YoY (from Rs. Key investor presentation takeaways from Himadri Speciality Chemical Ltd's Q3 FY25 investor presentation — and how it ranks
- Gujarat Alkalies & Chemicals Ltd (Q3 FY25)
3,702.77 Crores (up from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY25 investor presentation — and how it ranks agains
- Balaji Amines Ltd (Q3 FY25)
Q3FY25 consolidated revenue from operations was ₹321 crore, down 18% YoY from ₹392 crore in Q3FY24 (Page 7). Key investor presentation takeaways from Balaji Ami
- Vidhi Specialty Food Ingredients Ltd (Q3 FY25)
Year-on-Year (Y-o-Y) Growth:** 56.5% increase . Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY25 investor presentation —
Frequently Asked Questions
What were Chemcon Speciality Chemicals Ltd Q3 FY25 results?
Q3 FY25 Revenue from Operations: Rs. Q3 FY25 EBITDA: Rs.
What is Chemcon Speciality Chemicals Ltd share price analysis?
Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemcon Speciality Chemicals Ltd planning capital expenditure?
Capacity expansion plans to add two new manufacturing units, P10 and P11, for organic chemicals.
Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.